Mobia Medical, Inc. (NASDAQ:MOBI) Receives $20.25 Average PT from Brokerages

Shares of Mobia Medical, Inc. (NASDAQ:MOBI) have received a consensus recommendation of “Moderate Buy” from the six ratings firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $20.25.

Several equities analysts have commented on MOBI shares. The Goldman Sachs Group assumed coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They set a “buy” rating and a $31.00 target price on the stock. BTIG Research began coverage on Mobia Medical in a report on Tuesday, June 2nd. They set a “buy” rating and a $19.00 target price on the stock. JPMorgan Chase & Co. assumed coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued an “overweight” rating and a $15.00 price objective for the company. Zacks Research raised Mobia Medical to a “hold” rating in a research note on Wednesday, June 3rd. Finally, Wolfe Research began coverage on Mobia Medical in a report on Tuesday, June 2nd. They set an “outperform” rating on the stock.

Mobia Medical Trading Down 1.8%

Shares of NASDAQ MOBI opened at $13.16 on Friday. Mobia Medical has a 52-week low of $10.19 and a 52-week high of $15.29. The stock has a market capitalization of $437.56 million, a price-to-earnings ratio of 66.00 and a beta of 2.84.

Mobia Medical (NASDAQ:MOBI) last posted its earnings results on Thursday, June 4th. The company reported $999.00 EPS for the quarter. The company had revenue of $12.07 million for the quarter.

Insider Activity

In other Mobia Medical news, Director Cynthia L. Lucchese purchased 125,000 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were purchased at an average price of $15.00 per share, for a total transaction of $1,875,000.00. Following the completion of the transaction, the director owned 125,000 shares in the company, valued at $1,875,000. This represents a ? increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Nelson Bunker Curnes purchased 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The stock was bought at an average price of $12.79 per share, with a total value of $63,950.00. Following the transaction, the chief financial officer directly owned 366,997 shares in the company, valued at $4,693,891.63. This trade represents a 1.38% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 1,273,332 shares of company stock valued at $19,088,930 in the last ninety days.